382 related articles for article (PubMed ID: 22236448)
1. Treatment of systemic lupus erythematosus: new advances in targeted therapy.
Lo MS; Tsokos GC
Ann N Y Acad Sci; 2012 Jan; 1247():138-52. PubMed ID: 22236448
[TBL] [Abstract][Full Text] [Related]
2. Lupus: novel therapies in clinical development.
Chugh PK
Eur J Intern Med; 2012 Apr; 23(3):212-8. PubMed ID: 22385876
[TBL] [Abstract][Full Text] [Related]
3. New treatments for SLE: cell-depleting and anti-cytokine therapies.
Anolik JH; Aringer M
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):859-78. PubMed ID: 16150407
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
Sthoeger Z; Sharabi A; Mozes E
J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
[TBL] [Abstract][Full Text] [Related]
5. B-cell-directed therapies in systemic lupus erythematosus.
Tieng AT; Peeva E
Semin Arthritis Rheum; 2008 Dec; 38(3):218-27. PubMed ID: 18206214
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
Mikita N; Ikeda T; Ishiguro M; Furukawa F
J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
[TBL] [Abstract][Full Text] [Related]
7. Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.
Mosak J; Furie R
Lupus; 2013 Apr; 22(4):361-71. PubMed ID: 23553779
[TBL] [Abstract][Full Text] [Related]
8. Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.
Fanouriakis A; Boumpas DT; Bertsias GK
Expert Rev Clin Pharmacol; 2011 Jul; 4(4):437-51. PubMed ID: 22114854
[TBL] [Abstract][Full Text] [Related]
9. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R; Albert D
Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
[TBL] [Abstract][Full Text] [Related]
10. B cell targeted therapies in autoimmune diseases.
Isenberg DA
J Rheumatol Suppl; 2006 May; 77():24-8. PubMed ID: 16652442
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
12. Anticytokine therapy in systemic lupus erythematosus.
Yoo DH
Lupus; 2010 Oct; 19(12):1460-7. PubMed ID: 20947558
[TBL] [Abstract][Full Text] [Related]
13. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
Murdaca G; Colombo BM; Puppo F
Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
[TBL] [Abstract][Full Text] [Related]
14. From mechanism to therapies in systemic lupus erythematosus.
Paley MA; Strand V; Kim AH
Curr Opin Rheumatol; 2017 Mar; 29(2):178-186. PubMed ID: 28118202
[TBL] [Abstract][Full Text] [Related]
15. Biologics in SLE: the current status.
Rajadhyaksha AG; Mehra S; Nadkar MY
J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
Lee HJ; Sinha AA
Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
[TBL] [Abstract][Full Text] [Related]
17. The B cell in systemic lupus erythaematosus: a rational target for more effective therapy.
Driver CB; Ishimori M; Weisman MH
Ann Rheum Dis; 2008 Oct; 67(10):1374-81. PubMed ID: 17720723
[TBL] [Abstract][Full Text] [Related]
18. Systemic lupus erythematosus in children: current and emerging therapies.
Macdermott EJ; Adams A; Lehman TJ
Lupus; 2007; 16(8):677-83. PubMed ID: 17711907
[TBL] [Abstract][Full Text] [Related]
19. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Merrill JT; Wallace DJ; Petri M; Kirou KA; Yao Y; White WI; Robbie G; Levin R; Berney SM; Chindalore V; Olsen N; Richman L; Le C; Jallal B; White B;
Ann Rheum Dis; 2011 Nov; 70(11):1905-13. PubMed ID: 21798883
[TBL] [Abstract][Full Text] [Related]
20. Treating lupus: from serendipity to sense, the rise of the new biologicals and other emerging therapies.
Sousa E; Isenberg D
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):563-74. PubMed ID: 19591785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
